[Effect of the angiotensin converting enzyme inhibitor, perindopril, on heart rhythm variability and adrenoreactivity in patients with ischemic heart disease associated with duodenal ulcer].
Linnik
S A
SA
Naurbieva
E N
EN
Ponomareva
E P
EP
D000311:Adrenal Glands / Q000187:drug effects* / Q000503:physiopathology*; D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000328:Adult; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000494:pharmacology / Q000627:therapeutic use*; D017298:Bisoprolol / Q000627:therapeutic use; D004381:Duodenal Ulcer / Q000150:complications* / Q000188:drug therapy / Q000503:physiopathology; D005260:Female; D006339:Heart Rate / Q000187:drug effects*; D006801:Humans; D008297:Male; D008875:Middle Aged; D017202:Myocardial Ischemia / Q000150:complications* / Q000188:drug therapy* / Q000503:physiopathology; D020913:Perindopril / Q000494:pharmacology / Q000627:therapeutic use*; D016896:Treatment Outcome
D000319:Adrenergic beta-Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D017298:Bisoprolol; D020913:Perindopril